These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16815860)

  • 1. Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in epsilon-sarcoglycan deficient mice.
    Yokoi F; Dang MT; Li J; Li Y
    J Biochem; 2006 Jul; 140(1):141-6. PubMed ID: 16815860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of mutations in the epsilon-sarcoglycan gene in patients with different subtypes of primary dystonias.
    Grundmann K; Laubis-Herrmann U; Dressler D; Vollmer-Haase J; Bauer P; Stuhrmann M; Schulte T; Schöls L; Topka H; Riess O
    Mov Disord; 2004 Nov; 19(11):1294-7. PubMed ID: 15390016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers.
    Hess CW; Raymond D; Aguiar Pde C; Frucht S; Shriberg J; Heiman GA; Kurlan R; Klein C; Bressman SB; Ozelius LJ; Saunders-Pullman R
    Neurology; 2007 Feb; 68(7):522-4. PubMed ID: 17296918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes.
    Tezenas du Montcel S; Clot F; Vidailhet M; Roze E; Damier P; Jedynak CP; Camuzat A; Lagueny A; Vercueil L; Doummar D; Guyant-Maréchal L; Houeto JL; Ponsot G; Thobois S; Cournelle MA; Durr A; Durif F; Echenne B; Hannequin D; Tranchant C; Brice A;
    J Med Genet; 2006 May; 43(5):394-400. PubMed ID: 16227522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype-genotype correlation in Dutch patients with myoclonus-dystonia.
    Gerrits MC; Foncke EM; de Haan R; Hedrich K; van de Leemput YL; Baas F; Ozelius LJ; Speelman JD; Klein C; Tijssen MA
    Neurology; 2006 Mar; 66(5):759-61. PubMed ID: 16534121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responsiveness to levodopa in epsilon-sarcoglycan deletions.
    Luciano MS; Ozelius L; Sims K; Raymond D; Liu L; Saunders-Pullman R
    Mov Disord; 2009 Feb; 24(3):425-8. PubMed ID: 19133653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of striatal dopaminergic neurotransmission in a mouse model of DYT11 myoclonus-dystonia.
    Zhang L; Yokoi F; Parsons DS; Standaert DG; Li Y
    PLoS One; 2012; 7(3):e33669. PubMed ID: 22438980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Jerky" dystonia in children: spectrum of phenotypes and genetic testing.
    Asmus F; Langseth A; Doherty E; Nestor T; Munz M; Gasser T; Lynch T; King MD
    Mov Disord; 2009 Apr; 24(5):702-9. PubMed ID: 19117362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic spectrum and sex effects in eleven myoclonus-dystonia families with epsilon-sarcoglycan mutations.
    Raymond D; Saunders-Pullman R; de Carvalho Aguiar P; Schule B; Kock N; Friedman J; Harris J; Ford B; Frucht S; Heiman GA; Jennings D; Doheny D; Brin MF; de Leon Brin D; Multhaupt-Buell T; Lang AE; Kurlan R; Klein C; Ozelius L; Bressman S
    Mov Disord; 2008 Mar; 23(4):588-92. PubMed ID: 18175340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exclusive paternal expression and novel alternatively spliced variants of epsilon-sarcoglycan mRNA in mouse brain.
    Yokoi F; Dang MT; Mitsui S; Li Y
    FEBS Lett; 2005 Aug; 579(21):4822-8. PubMed ID: 16099459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epsilon-sarcoglycan mutations found in combination with other dystonia gene mutations.
    Klein C; Liu L; Doheny D; Kock N; Müller B; de Carvalho Aguiar P; Leung J; de Leon D; Bressman SB; Silverman J; Smith C; Danisi F; Morrison C; Walker RH; Velickovic M; Schwinger E; Kramer PL; Breakefield XO; Brin MF; Ozelius LJ
    Ann Neurol; 2002 Nov; 52(5):675-9. PubMed ID: 12402271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the epsilon-sarcoglycan gene in familial and sporadic myoclonus-dystonia: evidence for genetic heterogeneity.
    Valente EM; Misbahuddin A; Brancati F; Placzek MR; Garavaglia B; Salvi S; Nemeth A; Shaw-Smith C; Nardocci N; Bentivoglio AR; Berardelli A; Eleopra R; Dallapiccola B; Warner TT
    Mov Disord; 2003 Sep; 18(9):1047-51. PubMed ID: 14502674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal nuclear envelopes in the striatum and motor deficits in DYT11 myoclonus-dystonia mouse models.
    Yokoi F; Dang MT; Zhou T; Li Y
    Hum Mol Genet; 2012 Feb; 21(4):916-25. PubMed ID: 22080833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene.
    Asmus F; Salih F; Hjermind LE; Ostergaard K; Munz M; Kühn AA; Dupont E; Kupsch A; Gasser T
    Ann Neurol; 2005 Nov; 58(5):792-7. PubMed ID: 16240355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited myoclonus-dystonia and epilepsy: further evidence of an association?
    O'Riordan S; Ozelius LJ; de Carvalho Aguiar P; Hutchinson M; King M; Lynch T
    Mov Disord; 2004 Dec; 19(12):1456-9. PubMed ID: 15389977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large deletions account for an increasing number of mutations in SGCE.
    Han F; Racacho L; Yang H; Read T; Suchowersky O; Lang AE; Grimes DA; Bulman DE
    Mov Disord; 2008 Feb; 23(3):456-60. PubMed ID: 18098280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype.
    Asmus F; Zimprich A; Tezenas Du Montcel S; Kabus C; Deuschl G; Kupsch A; Ziemann U; Castro M; Kühn AA; Strom TM; Vidailhet M; Bhatia KP; Dürr A; Wood NW; Brice A; Gasser T
    Ann Neurol; 2002 Oct; 52(4):489-92. PubMed ID: 12325078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is psychopathology part of the phenotypic spectrum of myoclonus-dystonia?: a study of a large Dutch M-D family.
    Foncke EM; Cath D; Zwinderman K; Smit J; Schmand B; Tijssen M
    Cogn Behav Neurol; 2009 Jun; 22(2):127-33. PubMed ID: 19506430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor deficits and hyperactivity in cerebral cortex-specific Dyt1 conditional knockout mice.
    Yokoi F; Dang MT; Mitsui S; Li J; Li Y
    J Biochem; 2008 Jan; 143(1):39-47. PubMed ID: 17956903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal nuclear envelope in the cerebellar Purkinje cells and impaired motor learning in DYT11 myoclonus-dystonia mouse models.
    Yokoi F; Dang MT; Yang G; Li J; Doroodchi A; Zhou T; Li Y
    Behav Brain Res; 2012 Feb; 227(1):12-20. PubMed ID: 22040906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.